Literature DB >> 12220612

Treatment of methamphetamine use disorders: an update.

Richard A Rawson1, Rachel Gonzales, Paul Brethen.   

Abstract

Methamphetamine (MA) is a major public health and criminal justice problem in much of the Western and Midwestern US, and its use seems to be increasing east of the Mississippi River. MA use can produce significant psychiatric and medical consequences, including psychosis, dependence, overdose, and death. Cognitive behavioral therapy and contingency management are among the most promising approaches for treatment of MA abuse and dependence. A multisite study evaluating the Matrix Model of outpatient treatment will soon be completed to provide data on this manualized approach. An ambitious program of pharmacotherapy development research is currently being sponsored by the National Institute on Drug Abuse (NIDA) in geographic areas significantly affected by MA use. The development of treatments for MA-related problems is particularly critical for a number of user groups including MA users who experience persistent psychosis, pregnant women and women with children, gay and bisexual men, and MA users involved in the criminal justice system. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220612     DOI: 10.1016/s0740-5472(02)00256-8

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  39 in total

1.  A Mental Health Intervention for Rural, Foster Children from Methamphetamine-involved Families: Experimental Assessment with Qualitative Elaboration.

Authors:  Wendy Haight; James Black; Kathryn Sheridan
Journal:  Child Youth Serv Rev       Date:  2010-10-01

2.  "They mess with me, I mess with them": Understanding physical aggression in rural girls and boys from methamphetamine-involved families.

Authors:  Wendy Haight; Jane Marshall; Sydney Hans; James Black; Kathryn Sheridan
Journal:  Child Youth Serv Rev       Date:  2010-10-01

Review 3.  The need for speed: an update on methamphetamine addiction.

Authors:  Alasdair M Barr; William J Panenka; G William MacEwan; Allen E Thornton; Donna J Lang; William G Honer; Tania Lecomte
Journal:  J Psychiatry Neurosci       Date:  2006-09       Impact factor: 6.186

4.  Case 1: The need for speed.

Authors:  Mark L Norris
Journal:  Paediatr Child Health       Date:  2008-01       Impact factor: 2.253

5.  Male methamphetamine-user inmates in prison treatment: during-treatment outcomes.

Authors:  George W Joe; Grace A Rowan-Szal; Jack M Greener; D Dwayne Simpson; Jerry Vance
Journal:  J Subst Abuse Treat       Date:  2009-10-03

Review 6.  The methamphetamine epidemic: implications for HIV prevention and treatment.

Authors:  Grant Colfax; Steven Shoptaw
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

7.  Acute, low-dose methamphetamine administration improves attention/information processing speed and working memory in methamphetamine-dependent individuals displaying poorer cognitive performance at baseline.

Authors:  James J Mahoney; Brian J Jackson; Ari D Kalechstein; Richard De La Garza; Thomas F Newton
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-11-29       Impact factor: 5.067

8.  Tripling of methamphetamine/amphetamine use among homeless and marginally housed persons, 1996-2003.

Authors:  Moupali Das-Douglas; Grant Colfax; Andrew R Moss; David R Bangsberg; Judith A Hahn
Journal:  J Urban Health       Date:  2007-12-27       Impact factor: 3.671

9.  Duration effects in contingency management treatment of methamphetamine disorders.

Authors:  John M Roll; Joy Chudzynski; Jennifer M Cameron; Donelle N Howell; Sterling McPherson
Journal:  Addict Behav       Date:  2013-04-03       Impact factor: 3.913

10.  Glial cell modulators attenuate methamphetamine self-administration in the rat.

Authors:  Sarah E Snider; Elizabeth S Hendrick; Patrick M Beardsley
Journal:  Eur J Pharmacol       Date:  2013-01-31       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.